Active · per the CBE, 28 September 2026
PanTera logo

PanTera

BE0784992591

Rechtspersoon Public limited company 1 establishment

PanTera is registered with the CBE as active in: Vervaardiging van overige farmaceutische producten. Public Limited, started on 20 April 2022, 1 establishment.

Boeretang 192, 2400 Mol pantera-life.com

Active for

4 year, 5 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Two loss years in a row NBB

    Negative result in 2024 and 2025.

  • Figures corrected NBB

    Corrected annual account filed for 2025.

Financials

Financial year 2025

PanTera from Mol, company number BE0784992591, closed financial year 2025 with a result of € -3.9 million after tax. For that financial year PanTera recorded revenue of € 13.3 million and equity of € 108.8 million. Compared with financial year 2024, the result moved from € -8.6 million to € -3.9 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 8, 2026.

What it is worth Growing

€ 108.8 million

▲ 34% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -3.9 million

▲ 55 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 34.1 million

▲ 39% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -13.6 million.

People and assets in 2025

Full-time equivalents

24.2

▲ 13.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 3.3 million

▲ 105% vs 2024

€ 136,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 179,102

▲ 267% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5.8 million

▲ 22% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 155 days on average.

Wages and social charges

€ 679,800

▲ 284% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
202320242025Change 2024 → 2025
Revenue € 38,354 € 1,597,004 € 13,277,221 ▲ € 11.7 million
Profit after taxes € -1,110,017 € -8,626,612 € -3,906,435 ▲ € 4.7 million
Equity € 40,189,983 € 80,966,944 € 108,809,235 ▲ 34%
Total debts € 4,193,881 € 4,974,613 € 6,954,209 ▲ 40%
Cash € 1,079,270 € 24,456,235 € 34,050,228 ▲ 39%
Land & buildings - € 1,996,398 € 3,101,882 ▲ 55%
Retained profit € -1,110,017 € -9,736,629 € -13,643,064 ▼ € 3.9 million
Bank debt € 2,000,000 € 0 € 0
Balance sheet total € 44,383,865 € 85,941,557 € 115,763,445 ▲ 35%
Employees (FTE) 6 10.4 24.2 ▲ 13.8

Key figures of PanTera, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PanTera?

What happened at PanTera in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Karen Verwimp stepped down as director. NBB
  • Jean-François Rivassou stepped down as director. NBB
  • Primix Bio Ventures BV stepped down as director. NBB
  • Henri De Romrée de Vichenet stepped down as director. NBB
  • Martijn Kleijwegt stepped down as director. NBB
  • Pascal De Langhe stepped down as director. NBB
  • Catherine Vandenborre stepped down as director. NBB
  • Corrected annual accounts filed for financial year 2025. filed late Source: NBB ↗

In short

From € 1.1 million loss in 2023 to € 3.9 million loss in 2025.

Paid € 1,290 in corporate taxes since 2023.

Pays suppliers within 155 days on average.

Management

The shares are held by Studiecentrum voor Kernenergie - Centre d'Etude de l'Energie Nucléaire (35.8%), ION Beam Applications (34.9%), LSP 7 Coöperatief U.A. (13%), Federale Participatie- en Investeringsmaatschappij (4.7%), Korys Investments (2.7%) and Eurazeo NovSanté Fund (2.6%).

See the full network in the app

Directors

According to the 2025 annual accounts

Karen Verwimp

Director

since 2024 · until 2030

Jean-François Rivassou

Director

since 2024 · until 2030

Primix Bio Ventures BV

Director · represented by Luc Dochez

Also active at: Vico Therapeutics International

since 2024 · until 2030

Henri De Romrée de Vichenet

Director

since 2024 · until 2030

Soumya Chandramouli

Director

since 2024 · until 2025

Martijn Kleijwegt

Director

since 2024 · until 2030

Thomas Pevenage

Director

since 2025 · until 2025

Pascal De Langhe

Director

since 2024 · until 2030

Catherine Vandenborre

Director

since 2025 · until 2030

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Boeretang 192

2400 Mol

2.338.498.467

Boeretang 200

2400 Mol

Active since 20 April 2022

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

AWS S3Font AwesomeGoogle AnalyticsNginxPHPWordPressYoast SEOjQuery

Hosting & Email

Email provider

Microsoft 365

Hosting

AMAZON-02 - Amazon.com, Inc., US

Domain

Domain

pantera-life.com

Registered

2022-06-28

Registrar

EuroDNS S.A.

Expires

2026-06-28

Website info

HTTPS Ja
Languages EN
Copyright 2026

Features

Webshop Blog Jobs Contact page

Security

✓ HTTPS
✓ SPF
✗ DMARC

Details

Company number
0784.992.591
VAT number
BE 0784.992.591
Registered office
Boeretang 192, 2400 Mol
Names & denominations
PanTera
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
20 April 2022
Peppol
Active · Active since 24 Jun 2025
Activities · NACE

Vervaardiging van overige farmaceutische producten

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overige gespecialiseerde wetenschappelijke en technische activiteiten

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Frequently asked questions

What does PanTera do?
PanTera is registered with the CBE as active in: Vervaardiging van overige farmaceutische producten. Public Limited, started on 20 April 2022, 1 establishment.
What is the address of PanTera?
The registered office of PanTera is located at Boeretang 192, 2400 Mol.
Is PanTera still active?
Yes. According to the CBE (28 September 2026) PanTera is active, legal situation “Normale toestand”, started on 20 April 2022.
Is PanTera registered on Peppol?
Yes, PanTera is registered on the Peppol network with ID 0208:0784992591.
What is the enterprise number of PanTera?
The enterprise number of PanTera is BE0784992591.
When was PanTera founded?
PanTera was founded on 20 April 2022.